Syn X Licenses Patents from U. of Ottawa

Syn X Pharma has exclusively licensed two patents from the University of Ottawa Heart Institute that cover natriuretic peptides in cardiovascular disease. The patents cover inventions by Adolfo de Bold, a professor of pathology and researcher at the UOHI.

De Bold discovered atrial natriuretic factor (ANF), and since October 2000 has been working with Syn X on developing a potential point-of-care test for cardiac diseases based on brain natriuretic peptide, a cardiac hormone related to ANF.

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.